Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data.
about
Management before hepatectomy for hepatocellular carcinoma with cirrhosisThe role of liver biopsy in chronic hepatitis C.Role of liver biopsy in management of chronic hepatitis C: a systematic review.Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms.Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development.Alcohol, postprandial plasma glucose, and prognosis of hepatocellular carcinoma.Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir and Ribavirin for Hepatitis C Virus Genotype 2-Infected Japanese Patients.Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis.Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.The efficacy and safety of dual oral therapy with daclatasvir and asunaprevir for genotype 1b in Japanese real-life settings.Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C.Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients.Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection.Daclatasvir + asunaprevir versus sofosbuvir/ledipasvir for hepatitis C genotype 1 in Japanese patients: an indirect comparison.Interleukin 28B polymorphism predicts interferon plus ribavirin treatment outcome in patients with hepatitis C virus-related liver cirrhosis: A multicenter retrospective study in Japan.Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus.HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients.Magnetic resonance laparoscopy: A new non-invasive technique for the assessment of chronic viral liver disease.
P2860
Q26783874-9FA3E038-3DE6-42D8-B68B-25F26A898881Q34984093-757CFAE1-4BF5-4634-AEA8-DB3CB563363FQ34984098-680EE15B-E9B2-46AE-B084-0483AE186599Q35044909-B58940F2-E430-43B6-8555-AD9D9EF3714CQ35907984-3477778B-EEB3-4573-B50D-76C39E9B74A6Q36329125-E71E1F9A-58E8-4E31-8DFB-87131EE41357Q36525528-B0025ADB-A6F1-444A-913E-466A70C3DC63Q38376454-32C7C0B8-416C-4645-9D60-5F6C03BADAB7Q38398290-BAC6BD87-0D83-48BC-89FB-044058C540B5Q39028524-9B8C9D9B-09A7-4F01-800D-A7552B761933Q40340001-BE91280B-0FA8-4C62-867E-7C8B740F8BA0Q40539146-0C25A12A-3789-4FFE-830A-A6903E897131Q40579878-FC4D7843-4BCF-4A86-90D0-FA818A165A65Q40583906-657DDAEE-6E53-401D-9965-9025D4301D54Q40960952-5E29027F-50F5-481B-A1AF-2F03C1F0242BQ42244565-A3CAC476-BFC2-4677-BE04-15563045CAEEQ45367944-C546E88F-9E72-4DE8-AF6D-5953DBCBEA56Q47138788-46CC0792-960E-4852-8E7D-285AC34D6BEEQ48508898-FE7550A0-0DCA-4D87-AAD5-0D91BF2B8C2C
P2860
Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Distinction between chronic he ...... using common laboratory data.
@ast
Distinction between chronic he ...... using common laboratory data.
@en
type
label
Distinction between chronic he ...... using common laboratory data.
@ast
Distinction between chronic he ...... using common laboratory data.
@en
prefLabel
Distinction between chronic he ...... using common laboratory data.
@ast
Distinction between chronic he ...... using common laboratory data.
@en
P2093
P1433
P1476
Distinction between chronic he ...... using common laboratory data.
@en
P2093
Kobayashi M
Murashima N
P304
P356
10.1016/S1386-6346(00)00074-7
P577
2000-11-01T00:00:00Z